Cours Alterola Biotech, Inc. Other OTC
Actions
ABTI
US02152V1035
Recherche biotechnologique et médicale
CA 2022 | - | CA 2023 | - | Capitalisation | 35,27 M 31,95 M |
---|---|---|---|---|---|
Résultat net 2022 | -6 M -5,44 M | Résultat net 2023 | -1 M -906 k | VE / CA 2022 | - |
Dette nette 2022 | 199 k 180 k | Dette nette 2023 | 1,41 M 1,27 M | VE / CA 2023 | - |
PER 2022 |
-26,2
x | PER 2023 |
-20,2
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 56,4% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
David Hitchcock
CEO | Chief Executive Officer | 61 | 18/05/22 |
Timothy Rogers
CHM | Chairman | 60 | 21/06/21 |
Colin Stott
COO | Chief Operating Officer | 57 | 21/06/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
David Hitchcock
CEO | Chief Executive Officer | 61 | 18/05/22 |
Nathan Thompson
BRD | Director/Board Member | - | 10/10/23 |
Daniel Reshef
BRD | Director/Board Member | 73 | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+3,91% | 109 Md | |
+10,87% | 105 Md | |
+1,28% | 22,25 Md | |
-13,14% | 22,09 Md | |
-7,05% | 18,68 Md | |
-38,36% | 17,58 Md | |
-10,66% | 16,85 Md | |
+3,75% | 13,76 Md | |
+36,70% | 12,46 Md |